Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study

INTRODUCTION: By inhibiting cyclooxygenase-2, nonsteroidal anti-inflammatory drugs (NSAIDs) decrease aromatase activity and might reduce breast cancer risk by suppressing estrogen synthesis. Epidemiologic evidence for a protective role of NSAIDs in breast cancer, however, is equivocal. METHODS: We t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gierach, Gretchen L, Lacey, James V, Schatzkin, Arthur, Leitzmann, Michael F, Richesson, Douglas, Hollenbeck, Albert R, Brinton, Louise A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397540/
https://www.ncbi.nlm.nih.gov/pubmed/18447943
http://dx.doi.org/10.1186/bcr2089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397540/
https://www.ncbi.nlm.nih.gov/pubmed/18447943
http://dx.doi.org/10.1186/bcr2089

Ejemplares similares